• Explore /
  • Poster
  • / ENCORE 601: A phase 2 study of entinostat in combination with pembrolizumab in patients with microsatellite stable metastatic colorectal cancer.

ENCORE 601: A phase 2 study of entinostat in combination with pembrolizumab in patients with microsatellite stable metastatic colorectal cancer.

Abstract Poster

Authors

Nilofer Saba Azad

Nilofer Saba Azad

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD

Nilofer Saba Azad , Keisuke Shirai , Autumn Jackson McRee , Mateusz Opyrchal , Douglas Buckner Johnson , Peter Ordentlich , Susan Brouwer , Serap Sankoh , Emmett V. Schmidt , Michael L. Meyers , Melissa Lynne Johnson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT02437136

Citation

J Clin Oncol 36, 2018 (suppl; abstr 3557)

DOI

10.1200/JCO.2018.36.15_suppl.3557

Abstract #

3557

Poster Bd #

50

Abstract Disclosures

Similar Posters

First Author: Melissa Lynne Johnson

First Author: Joyce O'Shaughnessy

First Author: Enrique Grande

First Author: Robin Kate Kelley